Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FY6HZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,756
Award facts
- Contract value 100% obligated
- $9,756.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This contract, valued at $9,756.31, utilizes firm fixed price terms and was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026.
MULTAQ (dronedarone) is an antiarrhythmic medication used to reduce the risk of cardiovascular events in patients with atrial fibrillation. AmerisourceBergen, as a major pharmaceutical distributor serving federal medical procurement needs, maintains an extensive portfolio of brand-name and generic medications through its relationship with the DLA Medical Supply Chain. The SPE2DX prime vendor contract enables the company to supply critical pharmaceutical commodities and medical supplies to support military healthcare programs globally, including the Defense Health Agency and other government healthcare systems. This specific delivery order fulfills immediate pharmaceutical supply requirements within the broader framework of the DLA's comprehensive pharmaceutical support operations.
Quick answers
Who was awarded contract SPE2DB25FY6HZ?
SPE2DB25FY6HZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FY6HZ worth?
The government has obligated $9,756 on SPE2DB25FY6HZ.
Is contract SPE2DB25FY6HZ an order under another contract?
Yes. SPE2DB25FY6HZ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY6HZ competed?
The extent of competition for SPE2DB25FY6HZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award